GE Healthcare Life Sciences becomes Cytiva | 合法醫療器材資訊網

2020年4月1日—AsDanaher's$21bnacquisitioncompletes,GELifeSciencesrebrandsto'Cytiva'and,withtheCOVID-19pandemic,itsCEOtellsusdemandis ...

In the one of the largest deals seen in the contract development and manufacturing organization (CDMO) sector, Danaher Corporation decided to spend $21.4bn (€19.5bn) to acquire GE Healthcare Life Sciences[1]​.

Now, with the deal complete, GE Healthcare Life Sciences has emerged at the other side rebranded as Cytiva.

The company will retain the same staff, which means that it will have 7,000 employees and possess operations in 40 countries, becoming part of Danaher Corporation Life Sciences platform.

CEO and president of Cytiva, Emmanuel Ligner, spoke to BioPharma-Reporter about his vision of ‘continuity’ for the business.

“We have a phenomenal heritage. We have great people and what they do really, really matters, in terms of providing the pharma and biotech industry with absolutely critical high-quality products and services,”​ Ligner outlined.